Illinois HB1770 mandates insurance coverage for treatments of genetic, rare, and unique conditions, including Ehlers-Danlos syndrome and altered drug.
Illinois HB1770 amends the Illinois Insurance Code to require insurance policies to cover medically necessary treatments for genetic, rare, unknown, or unnamed conditions, including Ehlers-Danlos syndrome and altered drug metabolism. The bill specifies that insurance policies covering prescription drugs must include coverage for opioid alternatives, medicines listed in the World Health Organization's Model List of Essential Medicines, and custom-made medications and medical food.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.